oncology Archives - Express Pharma

Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001

Sun Pharma and Philogen sign global licensing agreement for Fibromun

Lupin launches Doxorubicin Hydrochloride Liposome Injection in the United States

Our aim is to tailor our oncology portfolio to address the most pressing needs in India

AstraZeneca sets $80 billion revenue target by 2030

Alembic Pharmaceuticals receives an EIR for its oncology formulation facility

Zydus launches IBYRA, the generic version of Olaparib

Oncology dominates CRISPR landscape: GlobalData

Colorectal cancer market across 8MM to reach $21.8 bn in 2031: GlobalData

Merck seeks to develop novel T-cell engager therapies with TriTAC platform: GlobalData